Come up with a name for your new list and we'll add to it:
Dynogen Pharmaceuticals raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
Dynogen is a biopharmaceutical company developing drugs for gastrointestinal (GI) and genitourinary (GU) disorders, including irritable bowel syndrome (IBS) and overactive bladder (OAB). Dynogen focus…